LatinaBA is a Contract Research Organization with more than 15 years in the market offering services in Latin America. We are experts in the region and have extensive experience conducting all phases of clinical trials including research with Medical Devices, Observational and RWE studies and Clinical Trial Oversight.
LAT RESEARCH SRL
LAT Research is a privately held Contract Research Organization (CRO), founded in 2010 and an active member of the Argentine Chamber of Clinical Research Organizations (CAOIC). We specialize in providing regulatory-compliant, high-quality clinical research services across Latin America. We partner with global sponsors to facilitate clinical development in alignment with international regulatory standards, including those of the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and ANMAT (Argentina’s National Administration of Drugs, Food and Medical Technology). ________________________________________ Clinical Trial Experience Since its establishment, our clinical operations team has supported more than 70 clinical trials across multiple phases and therapeutic areas. Our proven track record includes • Orphan and rare diseases • Translational medicine • Neglected and infectious diseases • Studies involving vulnerable or underserved populations Our operational strategies are aligned with ICH-GCP guidelines and tailored to meet both regional and global regulatory expectations. Regional Capabilities LAT Research is led by a team of senior physicians and industry experts with over 25 years of experience in clinical development and regulatory affairs. We maintain dedicated teams across Latin America, allowing for • Efficient site selection and patient recruitment • Deep understanding of local regulatory frameworks (FDA, EMA, ANMAT, INVIMA, COFEPRIS, among others) • Seamless coordination of multicenter studies Comprehensive Services for Sponsors We offer full-service CRO capabilities from early-phase trials through to registration and post-marketing studies, including: • Clinical development • Regulatory strategy and submissions • Site management and monitoring • Data management and biostatistics • Pharmacovigilance • Quality assurance and audit support Why Global Sponsors Choose LAT Research • Expertise in regulatory navigation across Latin American countries • Proven performance in complex, multicenter studies • Strong investigator networks and KOL relationships • Flexibility and client-centered project delivery • Commitment to quality, ethics, and operational excellence
Laboratorios Richmond SACIF
Richmond CDMO fully-integrated biotech services from development to supply chain. Single-use upstream and downstream GMP processing Mammalian cell culture platform for recombinant proteins and adenoviruses Fully automated filling and packaging lines for vials, pfs and cartridges. | We are a regional pharmaceutical company and CDMO based in Argentina that develops and produces medicines using cutting-edge technology. Our portfolio includes generic products, biosimilars, and technology licenses and transfers from key countries. We also create innovative solutions by combining different active ingredients in a single tablet and developing user-friendly packaging that facilitates therapeutic adherence and significantly improves our patients’ quality of life. Biotechnology Plant: A unit dedicated to the production of 100% of the production cycle for both vaccines and complex biotechnological products. As CDMO we offer our development and production capacity for biologicals, including vaccines and biosimilars. The plant has over 10,000 m2 dedicated to the production of biological active ingredients and finished products, it includes a GMP-compliant pilot plant and QC laboratories. The plant is equipped with single-use technology (upto 1000-L bioprocess) and has completely independent F&F areas distributed across two lines, providing maximum flexibility. The total estimated capacity will be approximately 80 million vials and 28 million syringes per year.
LABORATORIOS CASASCO
Laboratorios Casasco is a pharmaceutical manufacturing company headquartered in Buenos Aires, Argentina. It was founded in 1876, making it one of the country’s oldest pharmaceutical companies. Our mission is to advance global health and well-being by developing pharmaceutical products of the highest quality, grounded in scientific excellence and ethical integrity. Our portfolio includes cardiovascular health, Urology, Neurology and psychiatry, Immunology, Endocrinology (e.g., diabetes), Anti-infectives, Gastrointestinal treatments, Women’s health, and preventive medicine. Born in the 19th century, walked along the 20th century, and entered the 21st century as an enduring Argentine endeavor through the centuries.
Laboratorio Elea
Elea Phoenix is a top Argentinean Laboratory that has been researching and developing trustworthy and innovative medicines for a wide range of medical specialities since 1939. With leading trademarks, research and development projects of our own and licences from International renowed Companies. With Industrial Manufacturing Plants that operate efficiently, a wide distribution network, we focus firmly on the development of new products, in the following areas: Oncology, Biotechnology, Cardiology, Neuropsychiatry, Woman`s Health. Laboratorio ELEA is currently working with monoclonal antibodies, recombinant proteins, synthetic peptides, therapeutic vaccines for oncology. We are the first Company to launch a monoclonal antibody in 1997 , and in 2014 we launched the first Biosimilar mAb for Rituximab and Bevacizumab in 2016 . Now with have a potfolio of over 600 products, ranking 2nd for OTC/RX products. We have a strong portfolio in Biotech, launching Biopharmaceutical products every 2 years. | Elea is a top Argentinean Laboratory that has been researching and developing trustworthy and innovative medicines for a wide range of medical specialities since 1939. With leading trademarks, research and development projects of our own and licences from International renowed Companies. With Industrial Manufacturing Plants in Argentina and Latam that operate efficiently, a wide distribution network in several countries, we focus firmly on the development of new products, in the following areas: Oncology, Biotechnology, Cardiology, Neuropsychiatry, Woman`s Health. Laboratorio ELEA is currently working with monoclonal antibodies, recombinant proteins, synthetic peptides, therapeutic vaccines for oncology. We are the first Company to launch a monoclonal antibody in 1997 , and in 2014 we launched the first Biosimilar mAb for Rituximab and Bevacizumab in 2016 . Now with have a potfolio of over 600 products, ranking 2nd for OTC/RX products. We have a strong portfolio in Biotech, launching Biopharmaceutical products every 2 years. | We are an Argentine pharmaceutical company with more than 80 years of experience, dedicated to the research, development, and manufacturing of quality medicines for various medical specialties. Since 1939, we have stood out for offering innovative solutions that improve the health and quality of life of people, both in Argentina and throughout Latin America. ✅ We integrate our own research and development, alliances with important international laboratories and high-tech production plants, ensuring that innovation is present in every stage of our process. All this, together with an extensive distribution network, positions us among the leaders in the Argentine pharmaceutical market. Our main therapeutic areas are: Women’s Health – Urology – Anti-infectives – Respiratory – Internal Medicine – Ophthalmology – Neurosciences – Cardiometabolism – Osteoarticular – Gastroenterology – Oncology and Biotechnology – HIV – Over-the-Counter. We have a strong portfolio of Biopharmaceutical products in the market (EPO, Rituximab, Bevacizumab, Trastuzumab, Adalimumab, Pembrolizumab, Racotumomab, Nimotuzumab).
L.O. Hunting Service
Hunting Argentina for ducks, doves, red stag, Axis deer, Blackbuck, fly fishing, sea fishing.
Knight Therapeutics Inc.
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America.
Juntas Illinois S.A.
ILLLINOIS: Over 80 years of Innovation and leadership in automotive parts. Founded in 1943, Juntas Illinois S.A. has established itself as a leading company in the Argentine industry, specializing in the manufacturing of gaskets, seals, sealants, head bolts, and valve guides/seats. The company operates a state of the art industrial plant recognized internationally, supported by a dedicated Research & Development Laboratory and a modern Logistics Center specialized in export operations. With more than 15,000 active part numbers and a continuously expanding product range, our catalog provides extensive coverage for both aftermarket and original equipment applications. Juntas Illinois has certified international standards: -Quality: ISO 9001 -Environment ISO 14001 -Top Grade Product tested according to the following standards: SAE 921484, DIN 52913, ASTM F36 y ASTM F37. Product lines: passenger vehicles, light commercial vehicles, heavy-duty applications, and agricultural machinery.